The estimated Net Worth of Victor Perlroth is at least $35.3 Million dollars as of 24 February 2022. Victor Perlroth owns over 1,340,000 units of Kodiak Sciences Inc stock worth over $5,355,054 and over the last 6 years he sold KOD stock worth over $12,261,000. In addition, he makes $17,642,000 as Chairman of the Board, President, and Chief Executive Officer at Kodiak Sciences Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Victor Perlroth KOD stock SEC Form 4 insiders trading
Victor has made over 1 trades of the Kodiak Sciences Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 1,340,000 units of KOD stock worth $12,261,000 on 24 February 2022.
The largest trade he's ever made was selling 1,340,000 units of Kodiak Sciences Inc stock on 24 February 2022 worth over $12,261,000. On average, Victor trades about 121,818 units every 0 days since 2018. As of 24 February 2022 he still owns at least 2,168,038 units of Kodiak Sciences Inc stock.
You can see the complete history of Victor Perlroth stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Victor Perlroth biography
Dr. Victor Perlroth M.D. serves as Chairman of the Board, President, Chief Executive Officer of the Company. Previously, Dr. Perlroth served as Venture Partner and then Entrepreneur in Residence at MPM Capital, a dedicated healthcare venture capital investment firm. In 2003, Dr. Perlroth co-founded Avidia Inc., a biopharmaceuticals drug discovery and development company which was acquired by Amgen Inc., where he served as General Manager and Vice President of Corporate Development. In this role, at various times he had broad management responsibility across both corporate and research and development activities. Previously, Dr. Perlroth worked at Guzik Technical Enterprises, an industry-leading provider of test equipment to the hard disk drive industry, where he was Chief Operating Officer. Dr. Perlroth earned his M.D. and M.B.A. degrees from Stanford University and an A.B. in Molecular Biology summa cum laude from Princeton University.
What is the salary of Victor Perlroth?
As the Chairman of the Board, President, and Chief Executive Officer of Kodiak Sciences Inc, the total compensation of Victor Perlroth at Kodiak Sciences Inc is $17,642,000. There are no executives at Kodiak Sciences Inc getting paid more.
How old is Victor Perlroth?
Victor Perlroth is 47, he's been the Chairman of the Board, President, and Chief Executive Officer of Kodiak Sciences Inc since . There are 10 older and 2 younger executives at Kodiak Sciences Inc. The oldest executive at Kodiak Sciences Inc is Robert Profusek, 70, who is the Lead Independent Director.
Insiders trading at Kodiak Sciences Inc
Over the last 6 years, insiders at Kodiak Sciences Inc have traded over $15,919,920 worth of Kodiak Sciences Inc stock and bought 10,439,459 units worth $472,964,631 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Bros. Advisors Lp667, L.P.B..., and Victor Perlroth. On average, Kodiak Sciences Inc executives and independent directors trade stock every 27 days with the average trade being worth of $393,170. The most recent stock trade was executed by John A. Borgeson on 15 June 2024, trading 5,494 units of KOD stock currently worth $13,570.
What does Kodiak Sciences Inc do?
about kodiak kodiak is a high-science retinal medicines development company. we are aspiring to build a dominant global retina franchise. we are developing a top pipeline of proprietary best-in-class medicines for the treatment of patients with age-related macular degeneration and diabetic eye disease, two leading causes of blindness. our science begins with an antibody biopolymer product platform merging the fields of biologics and chemistry based therapies. in our medicines we aim to restore vision, to stop progression of underlying disease, and to require fewer treatments. working at kodiak we are passionate about preventing blindness and improving health. we take pride in scientific and operational excellence. the curiosity, creativity, and courage of our team members drives our progress. we highly value this culture and support it every way we can. kodiak supports a vibrant and active lifestyle. we have a top benefits package. we are within walking distance to california avenue sh
What does Kodiak Sciences Inc's logo look like?
Complete history of Victor Perlroth stock trades at Kodiak Sciences Inc
Kodiak Sciences Inc executives and stock owners
Kodiak Sciences Inc executives and other stock owners filed with the SEC include:
-
Victor Perlroth,
Chairman of the Board, President, Chief Executive Officer -
Jason Ehrlich,
Chief Medical Officer and Chief Development Officer -
John Borgeson,
Chief Financial Officer, Senior Vice President, Secretary -
Dr. Victor Perlroth M.D.,
Co-Founder, Chairman, CEO & Pres -
Dr. Jason S. Ehrlich M.D., Ph.D.,
Chief Medical Officer & Chief Devel. Officer -
John A. Borgeson CPA, M.B.A., MBA, CPA,
Sr. VP, CFO & Sec. -
Taiyin Yang,
Independent Director -
Robert Profusek,
Lead Independent Director -
Bassil Dahiyat,
Independent Director -
Richard Levy,
Independent Director -
Felix Baker,
Independent Director -
Charles Bancroft,
Independent Director -
Almas Qudrat M.Sc.,
Sr. VP of Quality Operations -
Dr. Hong Liang,
Sr. VP of Discovery Medicine -
Hong Liang,
See Remarks -
Bros. Advisors Lp667, L.P.B...,